*By Christian Smith*
After an overdose earlier this week, Demi Lovato's life was reportedly saved by Narcan, a nasal administrator of naloxone that counteracts the effects of opioids. When administered quicklyーthrough either nasal mist or injectionーnaloxone can temporarily halt an overdose, allowing EMTs enough time to respond. The medication is available without a prescription in 49 states, and the generic version costs about $20 per dose.
But all merits aside, is the drug's accessibility enabling addicts to push their limits?
Dr. Roger Crystal, the lead inventor of Narcan and CEO of Opiant Pharmaceuticals, says there's little evidence to support that concern.
"Addiction like any kind of chronic disease is something you can control using better medication, but ultimately you can't cure," Crystal told Cheddar. "To think about an opioid addict behaving rationally and saying, 'well because I have access to Narcan I'll shoot more heroin, inject more heroin' there's no proof for that whatsoever."
Naloxone is considered some of the best ammunition on the front lines of America's growing opioid epidemic. A reported 2 million Americans have an addition to opioidsーand the number isn't going down. U.S. Surgeon General Jerome Adams [issued an advisory](https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html) in April urging anyoneーand their close family and friendsーwho uses painkillers, heroin, fentanyl, or other opioids to carry naloxone in case of an emergency.
Crystal isn't stopping at Narcan: he told Cheddar he's also developing a heroin vaccine, suggesting the inventor has lofty ambitions for the future of overdose prevention.
Although Crystal may be aware of lingering ethical concerns, he doesn't think they dwarf his mission. After all, Lovato has him to thank.
"Putting it in the hands of everyone and anyone is critical," Crystal said.
For more on this story, [click here](https://cheddar.com/videos/how-one-pharmaceutical-company-is-fighting-the-opioid-epidemic).
Max Lugavere explains why no one should copy President Trump's diet. Lugavere is the author of a new book titled "Genius Foods: Become Smarter, Happier, and More Productive While Protecting Your Brain For Life."
Sarah Lewin, associate editor for Space.com, discusses the recent government shutdown that caused delays at NASA over the weekend.
Rachel Feltman, science editor at PopSci, discusses the recent NASA report that found 2017 was the second warmest year on record, only behind 2016.
In this week's episode of The Crypto Craze Cheddar Anchors Brad Smith and Baker Machado explain the biggest trends in the market. Cable and satellite entertainment company Starz filed a petition, asking the FCC to step in to resolve a fight with Altice. Facebook announces an update to its news policy. Amazon is increasing its prices.
On Your Future Home: Housing trends and tips with Quicken Loans. On Between Bells: the latest from Sundance Film Festival, counting down to the government shutdown, and more. With WeWork, The Coca-Cola Company and realtor.com.
When you go to the doctor and have to strip down into a gown, it can be a little uncomfortable. Care+Wear and Parsons School Of Design are teaming up to change that.
The Girl Scouts of the USA is launching its first-ever STEM education initiative for middle and high-school students. CEO Sylvia Acevedo joins Cheddar to discuss what the newly-enrolled girls will get to experience when they sign up for the program.
Amelia Urry, associate editor at The Grist, discusses the recent report by NASA which found 2017 was the warmest year on record, second only to 2016.
Kelly Beatty, senior editor of Sky & Telescope, talks SpaceX's powerful Falcon Heavy rocket, the possibility of a tax break for the company, and the upcoming lunar eclipse. The Falcon Heavy rocket is the most powerful this generation has ever seen.
Lindsey Shepard, Director of Product Marketing for News Feed at Facebook, says the update is meant to make people's time on the platform enjoyable, which in turn will be good for businesses.
Load More